Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (441-450 of 467) with videos related to

Pageof 47
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort SettingLauren Greenberg, Lene Ryom, Gilles Wandeler, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2020
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, ItalyFabio Ciceri, Antonella Castagna, Patrizia Rovere-Querini, et al.
The Lancet. HIV|June 10, 2022
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortiumBastian Neesgaard, Lauren Greenberg, Jose M Miró, et al.
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Plos Medicine|October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
AIDS (London, England)|August 24, 2022
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIVNadine Jaschinski, Lauren Greenberg, Bastian Neesgaard, et al.
Open Forum Infectious Diseases|July 20, 2021
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day MortalitySusan A Olender, Theresa L Walunas, Esteban Martinez, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseasesGiulio Guerrini, Fabio Franzetti, Roberto Giacomelli, et al.
Pageof 47

Showing results (441-450 of 467) with videos related to

Sort By:
Pageof 47
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort SettingLauren Greenberg, Lene Ryom, Gilles Wandeler, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2020
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, ItalyFabio Ciceri, Antonella Castagna, Patrizia Rovere-Querini, et al.
The Lancet. HIV|June 10, 2022
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortiumBastian Neesgaard, Lauren Greenberg, Jose M Miró, et al.
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Plos Medicine|October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
AIDS (London, England)|August 24, 2022
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIVNadine Jaschinski, Lauren Greenberg, Bastian Neesgaard, et al.
Open Forum Infectious Diseases|July 20, 2021
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day MortalitySusan A Olender, Theresa L Walunas, Esteban Martinez, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseasesGiulio Guerrini, Fabio Franzetti, Roberto Giacomelli, et al.
Pageof 47